Nengming Lin

1.2k citations
55 papers · 870 indexed · h-index 19
Topics
Ubiquitin and proteasome pathways (9 papers)Lung Cancer Treatments and Mutations (7 papers)Lung Cancer Research Studies (7 papers)
Journals
SHILAP Revista de lepidopterologíaCancer ResearchOncogene
Partner nations
ChinaMacaoNew Zealand

In The Last Decade

Nengming Lin

51 papers receiving 862 citations

Peers

Nengming Lin
Comparison fields: 5 of 85
  • Molecular Biology 569
  • Oncology 221
  • Pulmonary and Respiratory Medicine 180
  • Cancer Research 173
  • Pathology and Forensic Medicine 72
Replace Xiaoqing Guan with:
Xiaoqing Guan China
Rareş Drulă Romania
Mihail Buse Romania
Zhenhua Lin China
Meng-Ning Wei China
Sung‐Gil Chi South Korea
Michele Tavecchio United States
Zhilin Zou China
Yidan Ren China
Constantin Busuioc Romania
Nengming Lin relative to Xiaoqing Guan China Xiaoqing Guan's profile →
Citations per field
00.5×5.8×
Xiaoqing Guan · 1×
Citations per year

Countries citing papers authored by Nengming Lin

Since Specialization
Citations

This map shows the geographic impact of Nengming Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nengming Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nengming Lin more than expected).

Fields of papers citing papers by Nengming Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nengming Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nengming Lin. The network helps show where Nengming Lin may publish in the future.

Co-authorship network of co-authors of Nengming Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Nengming Lin. A scholar is included among the top collaborators of Nengming Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nengming Lin. Nengming Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 0
3 9
4 5
5 16
6 2
7 16
8 0
9 25
10 12
11 65
12 16
13 15
14 22
15 10
16 57
17 36
18 46
19 18
20 8

About Nengming Lin

Nengming Lin is a scholar working on Cancer Research, Oncology and Toxicology, having authored 55 papers that have together received 870 indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (9 papers), Lung Cancer Treatments and Mutations (7 papers) and Lung Cancer Research Studies (7 papers). The work is most often cited by research in Cancer Research (173 citations), Molecular Biology (569 citations) and Oncology (221 citations). Nengming Lin has collaborated with scholars based in China, Macao and New Zealand. Frequent co-authors include Chong Zhang, Lin‐wen Wu, Biqin Tan, Qiaojun He, Bo Zhang, Yang-ling Li, Youyou Yan, Hong Zhu, Linghui Zeng and Bo Yang. Their work appears in journals such as SHILAP Revista de lepidopterología, Cancer Research and Oncogene.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026